Fundraising Fox
/People
Sign in

Martin Münchbach

Investor

Managing Partner at Pureos Bioventures

Zurich, Switzerland

Writes $100K – $5M checks · typically $1.5M

Find your path to Martin

95 people in our graph can introduce you to Martin.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Klaus Breiner to introduce you to Martin

You →Klaus · together at Bellevue Asset Management (2004–2021) →Martin

Ask Jamie Chen to introduce you to Martin

You →Jamie · together at Bellevue Asset Management →Martin

Ask Sam Okafor to introduce you to Martin

You →Sam · 2 people · together at Citryll →Martin

Sign up to find every way you can get introduced to Martin

  • Your email: the people you already email who know Martin
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Martin
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Contact· self-published, not guessed

Experience

  1. Pureos BioventuresManaging Partnercurrent2017 — presentZürich Area, Switzerland
  2. CitryllBoard Observercurrent2024 — presentOss, North Brabant, Netherlands
  3. Ypsomed AGBoard Membercurrent2019 — presentBurgdorf, Switzerland
  4. CASCINATIONMember Board of Directorscurrent2025 — presentBerne, Switzerland
  5. River Renal IncBoard Membercurrent2021 — presentNew York, Vereinigte Staaten von Amerika
  6. Alentis TherapeuticsBoard Observercurrent2019 — presentBasel, Kanton Basel-Stadt, Schweiz
  7. Ariceum TherapeuticsBoard Member2021 — 2025Munich, Bavaria, Germany
  8. Binx HealthBoard Member2011 — 2022Trowbridge, UK
  9. Tioga Pharmaceuticals, Inc.Board Member2005 — 2022Greater San Diego Area
  10. Lava Therapeutics B.V.Board Observer2020 — 2021Utrecht, Niederlande
  11. Bellevue Asset ManagementSenior Investment Manager Private Equity2004 — 2021Zürich Area, Switzerland
  12. Opsona TherapeuticsBoard Member2013 — 2019Dublin, Ireland
  13. Sonetik AGBoard Member2009 — 2019Zürich, Kanton Zürich, Schweiz
  14. Aleva Neurotherapeutics SABoard Member2016 — 2017Lausanne Area, Switzerland
  15. Radius Health, Inc.Board Member2007 — 2016Greater Boston Area
  16. Molecular Partners AGBoard Observer2007 — 2013Zurich, Switzerland
  17. Optimer PharmaceuticalsBoard Member2005 — 2008Greater San Diego Area
  18. Glycart Biotechnology AGBoard Observer2003 — 2005Zurich, Switzerland
  19. NMT New Medical Technologies/HBM Partners AG/BioMedinvestInvestment Manager1999 — 2004Basel/Zurich
  20. Axovan AGBoard Observer2000 — 2003Basel Area, Switzerland

Skills & more

Strategy12Pharmaceutical Industry26Biotechnology44Venture Capital51Medical Devices11Lifesciences31Technology Transfer19Commercialization22Clinical Development10R&D6Mergers & Acquisitions6Biopharmaceuticals10
+12 moreStart-upsLicensingCorporate DevelopmentVenture FinancingAngel InvestingOncologyPatentsDue DiligenceDrug DiscoveryMolecular BiologyIPOHardware Diagnostics

From Martin's professional profile.

Investments

Investor

Ariceum TherapeuticsBioVascularMolecular PartnersOpsonaRadius HealthTioga Pharmaceuticals

Per curated public sources.

Colleagues at Pureos Bioventures

Anne Grahl
Associate at Pureos Bioventures
Butrint Aliu
Analyst at Pureos Bioventures
Christian Altorfer
CFO/COO at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Veronica Gambillara Fonck
Partner at Pureos Bioventures

Frequently asked questions

Who is Martin Münchbach?
Managing Partner at Pureos Bioventures
Where does Martin Münchbach work?
Martin Münchbach is Managing Partner at Pureos Bioventures.
What check size does Martin Münchbach write?
Martin Münchbach typically writes checks of $100K – $5M.
What companies has Martin Münchbach invested in?
Investments tracked here include Ariceum Therapeutics, BioVascular, Molecular Partners, Opsona, Radius Health, Tioga Pharmaceuticals.
Where did Martin Münchbach go to school?
Martin Münchbach studied at ETH Zürich (Dr. rer. nat. ETHZ, Proteinchemistry); ETH Zürich (MAS ETH MTEC, MAS ETH in Management); ETH Zürich (Dipl Natw. ETHZ, Biochemistry).

Same school

Shared employers